American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

Published on by AHNS Webmaster

Great Debate! SLNBx vs. MRND in Early Stage Oral Cavity Moderator: Susan McCammon, MD Panelists: Stephen Lai, MD & Eric Genden, MD

• Early Stage Oral Cavity Cancer – Neck no Neck? Let’s get ready to rumble. Dr. Genden representing the
Upper East Side of NYC, the heavy weight contender taking on the down south phenom Dr. Lai.

• Blows will be traded, data will be dropped. Judges Decision or Knockout? Come find out at Great Debate!

#AHNS2022
#Technology and Innovation

Register for the Annual Meeting!

Published on by AHNS Webmaster

Today! Starting in 1 Hour at Noon Eastern Time – Global Symposium Bridging Continental Divides: Challenges and Opportunities in Head Neck Oncology Practice in Low Resource Settings

Greetings,

On behalf of the AHNS Global Outreach Service we are pleased to invite you to a free Global Symposium. Bridging Continental Divides: Challenges and Opportunities in Head Neck Oncology Practice in Low Resource Settings.

Today, Saturday, April 23, 2022

12:00pm Eastern/11:00am Central/10:00am Mountain/9:00am Pacific

This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.

Learning objective:
This webinar presents perspectives from a panel of leading surgeons from underdeveloped regions and global moderators with extensive experience collaborating in these regions.

Please register on the link provided below for this free Global Symposium!
https://us06web.zoom.us/webinar/register/WN_AQXXbYvpQGSHip8Tw0KiTQ

Thank you,
AHNS Global Outreach Service

Published on by AHNS Webmaster

John Conley Lecture Thursday, April 28, 2022 8:00 AM – 9:00 AM CT Location: Landmark A

John Conley Lecture

Thursday, April 28, 2022

8:00 AM – 9:00 AM CT

Location: Landmark A

Robert L. Ferris, MD, PhD is Hillman Professor of Oncology and Director of the UPMC Hillman Cancer Center. He is Associate Vice Chancellor for Cancer Research, and Professor of Otolaryngology, Immunology, and Radiation Oncology at the University of Pittsburgh. As a head and neck surgical oncologist and translational tumor immunologist, his lab is focused on  reversal of immune escape and immunotherapy in head and neck cancer, which led to the first positive randomized phase III trial of head and cancer immunotherapy. He is Principal Investigator of the Pitt Specialized Program of Research Excellence (SPORE) grant for translational head and neck research and has been continuously NIH R01 funded for >15 years. As the PI for E3311, A Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer by the ECOG-ACRIN Cancer Research Group, Dr Ferris has demonstrated that surgical trials can be highly impactful.  He will be describing this trial and much more so please join us for the John Conley Lecture during the AHNS meeting at COSM!

#AHNS2022 #Technology and Innovation